- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02043782
Investigation of a New 1-piece Convex Ostomy Product
Investigation of a New 1-piece Convex Ostomy Product in Subjects With Ileostomy and Colostomy
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Søborg, Denmark
- TFS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Are at least 18 years of age and have full legal capacity.
- Have had an ileostomy/colostomy for more than 3 months
- Have used a 1-piece flat ostomy product for the last 1 month
- Has given written Informed Consent and signed the letter of authority
- Have an ileostomy or colostomy with a diameter of 33 mm or less
- Has experienced leakage (seeping) under the baseplate at least three times during the last two weeks
- Are evaluated to be suitable for a soft convex product
- If having a colostomy: changes their product on average 2 times pr. 24h or more
- Currently uses a bag of size medi/midi or maxi
Exclusion Criteria:
- Have a loop ostomy (also called double-barrel or ostomy with two outlets).
- Are pregnant or breastfeeding
- Currently receiving or have within the past 2 month received radio- and/or chemotherapy
- Currently receiving or have within the past month received systemic or local steroid treatment in the peristomal area
- Currently suffering from peristomal skin problems (i.e. bleeding or broken skin).
- Known hypersensitivity toward any of the test products
- Participating in other interventional clinical investigations or have previously participated in this investigation
- Use irrigation during the investigation (flush the intestine with water)
- Have a fistula in the peristomal area or less than 2 cm from the edge of the baseplate
- If subject has a colostomy: empties the bag
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: First Coloplast Test
The subjects are randomised 1:1:1 into six possible treatment groups to ensure random allocation of the treatments to the periods. First subjects are allocated to Coloplast Test; Secondly to either
|
Newly developed 1-piece convex ostomy product
The subjects Own product is used as baseline performance in this investigation.
The products are commercial and available on the market, and are products manufactured by manufactures who produce convex ostomy products i.e.
Coloplast, Convatec, Dansac, B.Braun, Hollister and more.
A commercially available soft convex product
|
Experimental: First Competitor soft convex
The subjects are randomised 1:1:1 into six possible treatment groups to ensure random allocation of the treatments to the periods. First subjects are allocated to Competitor soft convex; Secondly to either
|
Newly developed 1-piece convex ostomy product
The subjects Own product is used as baseline performance in this investigation.
The products are commercial and available on the market, and are products manufactured by manufactures who produce convex ostomy products i.e.
Coloplast, Convatec, Dansac, B.Braun, Hollister and more.
A commercially available soft convex product
|
Experimental: First Own product
The subjects are randomised 1:1:1 into six possible treatment groups to ensure random allocation of the treatments to the periods. First subjects are allocated to Own product; Secondly to either
|
Newly developed 1-piece convex ostomy product
The subjects Own product is used as baseline performance in this investigation.
The products are commercial and available on the market, and are products manufactured by manufactures who produce convex ostomy products i.e.
Coloplast, Convatec, Dansac, B.Braun, Hollister and more.
A commercially available soft convex product
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Degree of Leakage
Time Frame: 14 +/- 3 days
|
The degree of leakage is investigated on a 32-point scale (including 0 for no leakage).
O represents no leakage and 32 represents the worst leakage.
|
14 +/- 3 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Birte P Jakobsen, MD, Coloplast A/S
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CP241
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stoma Ileostomy
-
Chang Gung Memorial HospitalConvaTect, TaiwanUnknownStoma Ileostomy | Stoma ColostomyTaiwan
-
11 Heath and Technologies LimitedThe Cleveland ClinicUnknownIleostomy; Complications | Ileostomy - StomaUnited States
-
Massachusetts General HospitalRecruitingSurgery | Ileostomy - Stoma | Colostomy StomaUnited States
-
BBraun Medical SASRecruitingEnterostomy | Stoma Ileostomy | Stoma ColostomySpain
-
Hospital de BasurtoAlberto Loizate Totoricaguena; Pedro García AlonsoUnknownIleostomy; Complications | Ileostomy - Stoma | Stoma Ileostomy | Ileus ParalyticSpain
-
Coloplast A/SCompleted
-
DHQ mardanDHQ HOSPITAL MARDANCompleted
-
Coloplast A/SIWK Health Centre; Children's National; Driscoll Children's HospitalWithdrawn
-
University of Kansas Medical CenterCompletedStoma IleostomyUnited States
-
University of Wisconsin, MadisonTerminatedIleostomy - StomaUnited States
Clinical Trials on Coloplast Test
-
Coloplast A/SCompletedIleostomy - StomaDenmark
-
Coloplast A/SCompleted
-
Coloplast A/SCompletedIleostomy - StomaNetherlands
-
Coloplast A/SCompletedIleostomy - Stoma | Colostomy - StomaDenmark
-
Coloplast A/SCompletedIleostomy - StomaDenmark, Netherlands, Norway, United Kingdom
-
Coloplast A/SCompletedStoma - IleostomyDenmark
-
Coloplast A/SCompletedColostomy Stoma | Ileostomy StomaDenmark
-
Coloplast A/SCompletedIncontinence, UrinaryDenmark
-
Coloplast A/SCompletedColostomy | IleostomyUnited States, United Kingdom, Netherlands, Denmark
-
Coloplast A/STerminated